LCRC Invited Speaker Series

(Sponsored CME series)

2008 - 2009 LCRC Seminar Series Schedule

Time & Location:

2nd and 4th Thursday, 12 Noon
Tulane:
JBJ - J. Bennett Johnston Building

(or otherwise noted)
1324 Tulane Avenue - Room 403
Map/DIrections - Contact

1st & 3rd Thursday, 12 Noon
LSU:
CSRB - Clinical Science Research Building

(or otherwise noted)
533 Bolivar St. - Room 563
Map/Directions - Contact

Schedule 2009 - 2008:

(For LCRC Speakers from 2006 to 2007, Click Here.)

Statement of Need: The purpose of the Louisiana Cancer Research Consortium Grand Rounds is to provide a forum for the physicians in the Consortium in which they will be able to improve their personal competency in designing appropriate treatment protocols for patients presenting with various cancers; foster faculty communication , inter-professional teaming and professionalism; meet the quality improvement guidelines in cancer care; stay abreast of the latest research and developments in cancer.

Target Audience:

Physicians-specialties: Physicians involved in treating cancer
Non-physicians (nurses, allied health, etc.) Allied health professionals in cancer care

Objectives: After participating in this CME Activity, the participant should be better able to:

Critically evaluate the research which relates to the treatment of patient population presenting with cancer in the metro
New Orleans area. (C)
Identify benefits and adverse effects of current therapies for cancer treatment. (C)
Describe the mechanisms behind the recommended therapies for treatment of specific cancers. (C)
Analyze data from clinical trials and latest breakthroughs in cancer research. (C)

Accreditation/Designation of Credit: Tulane University Health Sciences Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

Tulane University Health Sciences Center designates this educational activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Tulane University Health Sciences Center presents this activity for educational purposes only and does not endorse any product, content of presentation or exhibit. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentation is provided solely by presenters who have been selected because of their recognized expertise.

Facilitated by: The Tulane University Health Sciences Center - Center for Continuing Education

Faculty Disclosure: It is the policy of Continuing Education at Tulane University Health Sciences Center to plan and implement all of its educational activities in accordance with the ACCME's Essential Areas and Policies to ensure balance, independence, objectivity and scientific rigor. In accordance with the ACCME's Standards for Commercial Support, everyone who is in a position to control the content of an educational activity certified for AMA PRA Category 1 Credit TM is required to disclose all relevant financial relationships with any commercial interests within the past 12 months that creates a real or apparent conflict of interest. Individuals who do not disclose are disqualified from participating in a CME activity.

Individuals with potential for influence or control of CME content include planners and planning committee members, authors, teachers, educational activity directors, educational partners, and others who participate, e.g. facilitators and moderators. This disclosure pertains to relationships with pharmaceutical companies, biomedical device manufacturers or other corporations whose products or services are related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be resolved prior to the educational activity. Disclosure of off-label, experimental or investigational drugs or devices must also be made known to the audience.

2009	Location		Speaker	Title
Jan 22	Tulane	*Paul A. Wade, PhD* Principal Investigator Eukaryotic Transcriptional Regulation Group National Institute of Environmental Health Sciences		"Epigenetic Regulation in Disease and Development"

Jan 29	Tulane	*Jianming Xu, PhD* Associate Professor Dept of Molecular and Cellular Biology Baylor College of Medicine		"Detrimental Contributions and Mechanisms of the p160 SRC Family in Breast & Prostate Tumorigenesis and Metastasis"

Feb 5	LSU	*Danny R. Welch, PhD* Professor of Pathology, Cell Biology, and Pharmacology University of Alabama at Birmingham		"Does the Mechanism of Action of Metastasis Suppressors Identify Targets for Cancer Therapeutics?"

Feb 26	Tulane	*Yiping Chen, PhD* Professor Department of Cell and Molecular Biology Tulane University		"Molecular Regulation of Palate Development & Cleft Palate Formation"

Mar 26	Tulane	*Michelle Barton, PhD* Associate Professor Department of Biochemistry and Molecular Biology MD Anderson Cancer Center		"TAP-ing Into p53 Funcitons in Normal Cells"

Apr 2	Tulane	*Christopher C. Benz, MD* Professor and Program Director Adjunct Professor of Medicine Buck Institute for Age Research		"New Biomarker and Therapeutic Approaches to Breast Cancer"

Apr 2	LSU	*Ching-Hon Pui, MD* Member, St. Jude Faculty Chair, Department of Oncology St. Jude Children's Research Hospital		"Recent Advances in Acute Lymphoblastic Leukemia"

Apr 9	Tulane	*Sendurai Mani, PhD* Principal Investigator Department of Molecular Pathology MD Anderson Cancer Center		"Generation of Stem-Like Cells via EMT; A New Twist on Cancer Initiation and Progression"

Apr 16	LSU	*Thao P. Dang, MD* Assistant Professor of Medicine Division of Hematology and Oncology Vanderbilt-Ingram Cancer Center		"Notch3 in Lung Cancer: From the Bedside to the Bench"

Apr 23	Tulane	*Michael F. Clarke, MD* Associate Director Stanford Institute for Stem Cell and Regenerative Medicine Stanford School of Medicine

May 7	LSU	*E. Premkumar Reddy, PhD* Director, Fels Institute for Cancer Research and Molecular Biology Temple University School of Medicine

May 14	Tulane	*Jonathan Melamed, MD* Associate Professor Department of Pathology MYU Langone Medical Center

May 28	LSU	*Jan K. Kitajewski, PhD* Associate Professor of Clinical Pathology Department of Pharmacology ACNC - Audobon

Jun 4	LSU	*Lily Wu, MD, PhD* Associate Professor Department of Molecular and Medical Pharmacology David Geffen School of Medicine at UCLA

Jun 11	Tulane	*Scott Hiebert, PhD* Professor of Biochemistry and Medicine Department of Biochemsitry Vanderbilt University

Jun 25	Tulane	*Shu-Yuan Yeh, PhD* Associate Professor Depts. of Urology, Pathology, and Laboratory Medicine University of Rochester Medical Center

Jul 9	Tulane	*Shiuan Chen, PhD* Director, Tumor Cell Biology Department of Surgical Research Beckman Research Institute

Jul 23	Tulane	*Marcus Peter, PhD* Professor Ben May Dept. for Cancer Research University of Chicago

Jul 30	Tulane	*Jin Yang, PhD* Assistant Professor Department of Pharmacology University of California, San Diego

Sept 10	Tulane	*Ann Nardulli, PhD* Professor Department of Molecular and Integrative Physiology University of Illinois at Urbana-Champaign

Nov 12	Tulane	*Suzanne Fuqua, PhD* Professor Department of Medicine and Molecular and Cellular Biology Baylor College of Medicine

Back to the top

2008	Location		Speaker	Title
Jan 10	Tulane	*Michael Mancini, PhD* Associate Professor, Director Integrated Microscopy Core Department of Molecular and Celluar Biology Baylor College of Medicine		"Systems Level Analysis of Nuclear Receptor Function by High Throughput Imaging"

Jan 24	Tulane	*Charles E. Wood, DVM, PhD* Assistant Professor of Pathology Comparative Medicine Wake Forest University		"Estrogens, Progestogens, and Breast Cancer Risk"

Jan 31	LSU	*Honnavara N. Anathaswamy, PhD* Deputy Department Chair Ashbel Smith Professor MD Anderson Cancer Center		"Role of p53 in UV-induced Apoptosis and Skin Carcinogenesis"

Feb 7	LSU	*Ross Kedl, PhD* Assistant Professor Department of Immunology University of Colorado		"Virtual Memory: A Novel Phenotype and Function for Antigen Specific T Cells in a Naive Host"

Feb 14	LSU	Mona Fouad, MD. MPH Professor of Medicine Director, Minority Health and Research Center University of Alabama School of Medicine Birmingham, Alabama		"Engaging Communities in Recruitment and Retention of Clinical Trials: It's All About Communication"

Feb 14	Tulane	Yong-Yu Liu, MD, PhD Assistant Professor of Pharmacology Department of Basic Pharmaceutical Sciences University of Louisiana College of Pharmacy		"Targeting Ceramide Glycosylation to Overcome Cancer Drug Resistance"

Feb 28	Tulane	*Frank Porreca, PhD* Proessor of Pharmacology University of Arizona		"Opioid Analgesia in the Setting of Bone Cancer Pain"

Mar 6	LSU	*Thomas F. Gajewski, MD, PhD* Associate Professor Department of Pathology and Medicine University of Chicago		"Overcoming Negative Regulation of T Cell Responses in the Tumor Microenvironment"

Mar 13	Tulane	*Dean Edwards, PhD* Professor, Department of Molecular and Cellular Biology and Pathology Baylor College of Medicine		"Bidirectional Cross-Talk Between Progesterone Receptors and Growth Factor Signaling Pathways: Role in Normal Mammary Gland Development and Breast Cancer"

Mar 20	LSU	*Srikumar Chellappan, PhD* Professor, Drug Discovery Program Department of Interdisciplinary Oncology H. Lee Moffitt Cancer Center and Research Institute, USF		"Rb-E2F Pathway in Cell Cycle Regulatioin and Lung Cancer"

Mar 27	LSU	Daniel W. Rosenberg, PhD Professor of Medicine Center for Molecular Medicine University of Connecticut Health Center		"Do Benign Colon Lesions Provide Insights Into the Early Stages of Cancer?"

Apr 3	LSU	*Michael Freeman, PhD* Associate Professor, Department of Surgery Harvard Medical School		"Cholesterol and Aggresive Prostate Cancer: Insights From Cell Signaling"

Apr 10	Tulane	Rachel Schiff, PhD Assistant Professor of Medicine Breast Center, Baylor College of Medicine		"Endocrine and antiHER2 Resistance: Mechanisms and New Therapeutic Strategies"

May 1	LSU	Prof. David Naor The Hebrew University - Hadassah Medical School, Israel		"The Involvement of CD44, a Molecule with Thousand Faces, in Cancer and Inflammation"

May 8	Tulane	*Billy Day, PhD* Professor, Department of Pharmaceutical Studies and Chemistry University of Pittsburgh		"Proteomics Analyses of Breast Cancer Models"

May 15	LSU	*Anjali Karande, PhD* Professor, Department of Biochemistry Indian Institute of Science Bangalore, India		"Glycodelin A: A Novel Human Galactose Specific Lectin with Immunoregulatory Activity"

May 22	Tulane	*Brian Schaefer, PhD* Assistant Professor, Department of Microbiology and Immunology Uniformed Services University of the Health Sciences		"Differential T Cell Receptor Signaling to NF-kB in the CD4+ and CD8+ T Cell Subsets"

May 29	Tulane	*Jiandong Chen, PhD* Professor, Molecular Oncology Program H. Lee Moffitt Cancer Center Tampa Florida		"MDM2 in Stress Signaling to p53"

Jun 5	LSU	*M. Ram Sairam, PhD* Director and Professor Molecular Reproduction Research Lab Clinical Research Institute of Montreal		"Chronology of Ovarian Tumorigenesis and Search for Novel Tumor Associated Genes-OTAGs"

Jun 19	LSU	*William Stratford May, MD , PhD* Harry F. Innes Professor of Medicine Director, Shands Cancer Center University of Florida		"Bcl2, Apoptosis, P53, and all that Jaz(z)"

July 10	Tulane	*Carolyn L. Smith, PhD* Associate Professor Department of Molecular and Cellular Biology Baylor College of Medicine		"Things are Looking Up for the SMRT Co-Repressor"

July 17	LSU	*Timothy Thompson, PhD* Professor Genitourinary Medical Oncology MD Anderson Cancer Center		"GLIPR1 - A Tumor Suppressor Protein and Potential Therapeutic Agent"

July 31	Tulane	*Judith Campisi, PhD* Professor Cell and Molecular Biology Buck Institute for Age Research		"Cancer and Aging: Rival Demons?"

Aug 14	Tulane	*Ann Richmond, PhD* Ingram Professor and Vice Chair Department of Cancer Biology Vanderbilt Ingram Cancer Center Vanderbilt Univ School of Medicine		"Defining the Chemosynapse"

Sep 11	Tulane	*Alea Mills, PhD* Associate Professor Cold Spring Harbor Laboratory Cold Spring Harbor, New York		"The Chromatin Remodeler CHD5 is a Tumor Suppressor for Mapping to1p36?"

Sep 25	Tulane	*Shuk-Mei Ho, PhD* Chair Department of Environmental Health University of Cincinnati		"Early Origins of Disease: Resurfacing of Dormant Epigenetic Memories Later-Life"

Oct 1	LSU	Bal Lokeshwar, PhD Associate Professor Department of Urology University of Miami School of Medicine		"Pro-Inflammatory Factors in Prostate Cancer Progression: From Smoldering to Blaze"

Oct 2	LSU	Sankar Mitra, PhD Professor and Vice Chair Department of Biochemistry and Molecular Biology University of Texas Medical Branch		"Cellular Responses to Genotoxicity of Reactive Oxygen Species"

Oct 16	Tulane	William Anderson MD, MPH Principal Investigator National Institute of Health Division of Cancer Epidemiology and Genetics		"Descriptive Epidemiology of Cancer Heterogenity"

Oct 16	LSU	Vinata Lokeshwar, PhD Professor of Urology Co-Director, Divison of Urology Research University of Miami Miller School of Medicine		"Hyaluronic Acid & Hyaluronidase: Tumor Marker to Therapeutics and DNA Methylation"

Oct 23	Tulane	*Yi Li, PhD, MS* Assistant Professor of Molecular and Cellular Biology, Breast Cancer Baylor College of Medicine		"Breast Cancer Initiations: Insights from Mouse Models"

Oct 30	Tulane	*Kenneth Nephew, PhD* Associate Professor, Assistant Director of Basic Science Research Indiana University School of Medicine		"Aberrant Estrogen Receptor Signaling & Epigenomic Alternations in Antiestrogen Resistant Breast Cancer"

Nov 6	LSU	Scott Durum, PhD Head, Immunological Cytokine Group Deputy Laboratory Chief NCI-Frederick		"IL-7 in the Life and Death of Lymphocytes"

Nov 13	Tulane	*Tracy Handel, PhD* Professor, University of California, San Deigo, Skaggs School of Pharmacy and Pharmaceutical Sciences		"Chemokine-Receptor & Function: Opportunities for Novel Therapeutic Strategies"

Nov 20	LSU	Krzysztof Reiss, PhD Associate Professor Dept. of Neuroscience and Neurovirology Temple University School of Medicine		"IGF-I Receptor and Human Polyomavirus JC Large T-Antigen in Malignant Transformation"

Dec 4	LSU	*Edward Trapido, ScD* Associate Director Epidemiology and Genetics Research Program National Cancer Institute		"Establishing National Comprehensive Cancer Control Programs in Developing Countries: International Agencies and the PACT Programme"